David Gibb
Program Director · Cedars-Sinai Medical Center
Credentials: · · · · · ·
History
Present- Present
- Present
2012–2015
Research
Molecular Biology of the Cell · 2009 · 220 citations
ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo
The Journal of Experimental Medicine · 2010 · First of 11 authors · 127 citations
Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity
The Journal of Immunology · 2012 · 75 citations
16 papers
- SS
9 papers · 3 as a fellow
9 papers
7 papers
- EK
6 papers
- SP
6 papers
5 papers
- JZ
5 papers
Grants
- 2022–2027
Autoantibody-Induced Type 1 Interferons and RBC Alloimmunization in Sickle Cell Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.1M · Cedars-Sinai Medical Center
- 2018–2024
The Role of Type 1 Interferon in Regulating Alloimmune Responses to Transfused Red Blood Cells
National Heart, Lung, and Blood Institute · K08
Contact PI · $820.3K · Cedars-Sinai Medical Center
- 2021–2023
Mechanisms Underlying Inflammation-Induced Alloimmunization to RBC Antigens in Lupus
National Heart, Lung, and Blood Institute · R03
Contact PI · $167K · Cedars-Sinai Medical Center